KT&G to explore new drugs after Mazence acquisitionKorea’s largest tobacco and ginseng company KT&G said yesterday it is expanding its development of new medical drugs as the company succeeded in acquiring a majority share of Mazence.
KT&G said it has bought a 60 percent stake in Mazence valued at roughly 30 billion won ($25.9 million).
Mazence, which was founded in 2002, has specialized in developing drugs to treat diabetes and obesity.
The company said in a statement that, with the acquisition of Mazence, it has set up a portfolio ranging from tobacco to health food products, cosmetics and new drugs that will help it grow into a competitive global player.
More in Industry
EuCorVac-19 vaccine gets greenlight for trials
Tesla model to lose government subsidies
Jailed Lee vows to support Samsung compliance committee
Samsung Display will make display with higher refresh rate
Clean start to the Lunar New Year